Is Amphastar Pharmaceuticals (AMPH) stock Halal?

Amphastar Pharmaceuticals is a specialty pharmaceutical company dedicated to the development, manufacture, and marketing of innovative generic and proprietary injectable, inhalation, and intranasal products. Amphastar's primary function is to provide cost-effective medications that improve patient care and accessibility to treatment. The company’s product portfolio includes critical drugs used in hospitals and other medical settings, targeting areas like endocrinology, anesthesia, and pain management. For Muslim investors, though, the most pressing question is simpler: is Amphastar Pharmaceuticals a Halal investment?

Is Amphastar Pharmaceuticals Shariah compliant?

No. In the October 2026 screening Amphastar Pharmaceuticals (AMPH) does not pass AAOIFI screening: it fails the interest-bearing debt screen. Medicines and medical devices are permissible, and healthcare companies like Amphastar Pharmaceuticals usually clear the activity screen comfortably. What AAOIFI Shariah Standard No. 21 watches is the financing behind the pipeline: drug development is expensive, and the 30% interest bearing debt cap decides the verdict more often than the science does.

Does Amphastar Pharmaceuticals pass the business activity test?

The activity screen is only part of the picture this month: Amphastar Pharmaceuticals currently fails the interest-bearing debt screen, so the overall verdict is not compliant regardless of the business itself. Treating illness is permissible work; the scrutiny belongs to the financing behind it.

Is Amphastar Pharmaceuticals' income Halal?

Yes, within AAOIFI's tolerance. Amphastar Pharmaceuticals' income from non-permissible sources stays below 5% of revenue in the October 2026 screening.

Does Amphastar Pharmaceuticals meet AAOIFI's debt and investment ratio requirements?

Not in full. Interest bearing debt currently exceeds the 30% cap, measured against a market capitalisation of $1.1B (market data as of 1 October 2026), while the other ratio stays within it. One breach is enough to fail the screening; the ratios are reassessed monthly under our Shariah Supervisory Board.

Why do other halal screeners show a different verdict for Amphastar Pharmaceuticals?

Screeners can disagree without either being wrong. AAOIFI Shariah Standard No. 21, which Tabadulat applies, measures interest bearing debt and investments against market capitalisation with a 30% ceiling. MSCI and FTSE measure them against total assets with a 33% ceiling, and S&P and Dow Jones Islamic use a multi year average of market capitalisation. Data dates differ too, because each provider reads filings and prices on its own schedule. The same company can therefore pass one standard and fail another in the same month. Tabadulat publishes one answer, the AAOIFI result as of October 2026, and re-screens it every month.

Tabadulat is an ADGM regulated brokerage whose license covers Shari'a Compliant Regulated Activities, as the FSRA permission names them. New to the terminology? Gharar and Maysir, Sukuk, Zakat and purification are all explained in plain English.

New to the screening method? Read What is Halal Investing? A Guide to Halal Stocks and Islamic Finance